The application of quantitative trade-off analysis to guide efficient medicine use within the UK NHS
Background: The UK National Health Service (NHS) currently spends in excess of £17 billion per annum on medicines. To ensure sustainability, medicines with limited clinical value should not be routinely prescribed. The randomised controlled trial (RCT) aims to meet regulatory standards, therefore it...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2018
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.747564 |